Computer Scientist & IT Analyst exploring neurotech, BCIs, and the future of human-computer synergy.
Aug 10, 2026
•
5 min read
Ten years of writing to a human brain: zero adverse events, and a third of the electrodes gone.
Jul 13, 2026
Seven weeks off. Here's what actually mattered in neurotech, ruthlessly filtered.
Neuralink
+5
May 24, 2026
Meta's NeuralBench lands; NEO goes commercial
Neurotechnology
+6
May 9, 2026
2 min read
Neuralink, SetPoint, ARIA each bet differently
May 2, 2026
Plus: depression implant clears FDA
Clinical Trial News
+3
Apr 25, 2026
Plus €40.6M and a stealth exit
Apr 18, 2026
Invasiveness tiers get crowded
Closed-loop DBS
Apr 11, 2026
8 min read
Plus: organoids go to war
Apr 4, 2026
9 min read
Plus: living-neuron BCIs get a surgeon
Mar 28, 2026
6 min read
Control, not just signal
Mar 21, 2026
14 min read
BCIs Close in on Normal Speed
Ethics & Policy
Mar 14, 2026
The Regulatory Finish Line Just Moved
Mar 8, 2026
16 min read
Science Corp. Leads the Pack
+7
Mar 1, 2026
12 min read
Plus: Japan's Stem Cell Gamble
Neuroscience
Feb 21, 2026
7 min read
Forecasting the Brain's Future
Feb 15, 2026
Real-World Decoding Advances
Feb 8, 2026
Poststroke outcomes, coverage signals
Feb 1, 2026
Long-horizon signals emerge
+4
Jan 24, 2026
Trials, implants, oversight
Jan 17, 2026
Trials, Funding, FDA Signals
Jan 11, 2026
Foundations, funding, and clarity
Dec 27, 2025
4 min read
Neuromodulation and measurement advance
Dec 20, 2025
Regulation, reality, deployment
Dec 13, 2025
BCIs, Stimulation, and Scale
Dec 6, 2025
Critical milestones in modern neurotech